brentuximab,Dacarbazine,Doxorubicin Hydrochloride,Filgrastim,Nivolumab,Pegfilgrastim,Vinblastine Sulfate
seagen,amgen,Bms
['opdivo', 'lymphoma', 'adcetris', 'seagen', 'bristol']
asco: seagen's top-selling drug under threat as bristol myers' opdivo beats adcetris in lymphoma 
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.